Pressmeddelande -

Göran Beijer joins NOLabs as CEO

NOLabs AB, the Swedish bio-medtech company announced that it has appointed Göran Beijer as its CEO from November 1, 2007.

Göran Beijer has a long range and wide experience from executive management positions within the life science industry. Prior to joining NOLabs he held positions in GE, Astra Zeneca and Tamro. Most recently he served as CEO for the Cerbo Group.


For more information please visit: www.nolabs.com

 

Ämnen

  • Ekonomi, finans

Kategorier

  • göran beijer
  • nolabs
  • diabetics
  • finance
  • kväveoxid
  • nitric oxid

Relaterad media

  • Göran Beijer
  • Licens: All rights reserved
    Innehållet får bara användas av Mynewsdesk. Det är alltså inte tillåtet för någon annan att ladda ner, kopiera, sprida eller på annat sätt använda Innehållet (annat än för privat bruk i den mån det följer av lag).
Inte nedladdningsbar

Relaterat innehåll

NOLabs AB achieves break-through in fight against MRSA-bacteria

NOLabs AB, the Swedish medtech company developing innovative nitric oxide-containing medical devices based on the NitroSense® Technology, today reported that it has achieved another important milestone in the development of a new line of products for wounds infected by MRSA-bacteria.

NOLabs will attend IN3 Europe Investment in Innovation - Paris

NOLabs AB will attend IN3 Europe Investment in Innovation on the 29-30th April. Take the opportunity to meet us there. We are one of the presenting companies and we will be on the big scene on the 29th April at 09.50am. Welcome!